Autoimmune thyroid diseases (AITDs) include a wide spectrum of thyroid diseases affecting
more commonly women than men. The most frequent forms are Graves' Disease (GD) and …

Immune checkpoint inhibitors (ICIs) are a group of drugs employed in the treatment of
various types of malignant tumors and improve the therapeutic effect. ICIs blocks negative co …

Thyroiditis is a general term for inflammation of the thyroid gland. The most common forms of
thyroiditis encountered by family physicians include Hashimoto, postpartum, and subacute …

Levothyroxine (LT4) is a safe, effective means of hormone replacement therapy for
hypothyroidism. Here, we review the pharmaceutical, pathophysiological and behavioural …

Background Previous studies showed that although the risk of thyroid dysfunction [thyroid
immune-related adverse events (irAEs)] induced by anti-programmed cell death-1 …

Background Anti-programmed cell death-1 (ligand-1) antibody [PD-(L) 1-Ab] can cause
destructive thyroiditis and/or hypothyroidism. In addition, tyrosine kinase inhibitors (TKIs) …

The retinoid X receptors (RXRs) are ligand-activated transcription factors involved in, for
example, differentiation and apoptosis regulation. Currently used reference RXR agonists …

Cancer-related fatigue (CRF) is a distressing side effect of cancer and treatment, affecting
both patients during active treatment and survivors, negatively impacting quality of life. While …

Although levothyroxine (LT4) is a widely prescribed drug, more than 30% of LT4-treated
patients fail to achieve the recommended serum level of thyrotropin with a body weight …

The clinical treatment of patients with cancer who are also diagnosed with coronavirus
disease (COVID-19) has been a challenging issue since the outbreak of COVID-19 …